{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:48:58Z","timestamp":1792000138208,"version":"4.4.0"},"reference-count":6,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Facial Plast Surg"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is a growing global health concern. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic, have emerged as potential treatments. GLP-1 receptor agonists regulate appetite and can promote weight loss. Some GLP-1 receptor agonists, though Food and Drug Administration (FDA)-approved for diabetes, are also used off-label for weight loss alone. Rapid weight and fat loss with these medications can lead to what has been called \u201cOzempic Face\u201d on social media and in the lay press, where facial volume and fat are depleted, resulting in wrinkles and sagging skin. Prescribers rarely counsel patients about the potential impact on the face, and the plastic surgery community faces a challenge in managing the facial changes associated with rapid weight loss. Dermal fillers, skin tightening techniques, and surgical interventions are useful for both restoration of facial volume and to manage excess skin. Discontinuation of GLP-1 receptor agonists should be considered prior to general anesthesia due to delayed gastric emptying while on these medications. As the popularity of GLP-1 receptor agonists grows, facial plastic surgeons must be aware of both the impact on facial appearance and perioperative considerations.<\/jats:p>","DOI":"10.1055\/a-2148-6321","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T19:12:52Z","timestamp":1691176372000},"page":"719-721","source":"Crossref","is-referenced-by-count":77,"title":["Implications of Ozempic and Other GLP-1 Receptor Agonists for Facial Plastic Surgeons"],"prefix":"10.1055","volume":"39","author":[{"given":"Clinton D.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9942-445X","authenticated-orcid":false,"given":"Anna C.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head and Neck Surgery, University of Kansas School of Medicine, Kansas City, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"19","key":"ref1","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2023.2438","article-title":"As Ozempic's popularity soars, here's what to know about semaglutide and weight loss","volume":"329","author":"M Suran","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"J PH Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"D Rubino","year":"2021","journal-title":"JAMA"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00266-015-0540-6","article-title":"Objective assessment of facial rejuvenation after massive weight loss","volume":"39","author":"R A Couto","year":"2015","journal-title":"Aesthetic Plast Surg"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cps.2019.05.003","article-title":"Facelift in patients with massive weight loss","volume":"46","author":"R A Couto","year":"2019","journal-title":"Clin Plast Surg"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.2023.9601","article-title":"Oral semaglutide led to similar weight loss as injection, company says","volume":"329","author":"E Harris","year":"2023","journal-title":"JAMA"}],"container-title":["Facial Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2148-6321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:56:53Z","timestamp":1730804213000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2148-6321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":6,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2023,10,31]]},"published-print":{"date-parts":[[2023,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2148-6321","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0736-6825","1098-8793"],"issn-type":[{"value":"0736-6825","type":"print"},{"value":"1098-8793","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8,4]]},"published":{"date-parts":[[2023,8,4]]}}}